Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity

BMC Physiology

Volumn 10, Issue 1, 2010, Pages

  Dal Pan, Alexandre ^a   Blanc, Stéphane ^b   Aujard, Fabienne ^a  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; PANCREAS POLYPEPTIDE; PEPTIDE YY; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; CALORIC INTAKE; DRUG EFFECT; ENERGY METABOLISM; MALE; MOTOR ACTIVITY; PROSIMIAN; PSYCHOPHYSIOLOGY; WEIGHT GAIN;

ANIMALS; CHEIROGALEIDAE; ENERGY INTAKE; ENERGY METABOLISM; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; MALE; MOTOR ACTIVITY; PANCREATIC POLYPEPTIDE; PEPTIDE YY; SATIETY RESPONSE; STILBENES; WEIGHT GAIN;

EID: 77953679841     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-10-11     Document Type: Article

References (40)

1. Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer. D Delmas A Lancon D Colin B Jannin N Latruffe, Curr Drug Targets 2006 7 423 442 10.2174/138945006776359331 16611030
2. Role of viticultural factors on stilbene concentrations of grapes and wine. L Bavaresco, Drugs Exp Clin Res 2003 29 181 7 15134373
3. Therapeutic potential of resveratrol: the in vivo evidence. JA Baur DA Sinclair, Nat Rev Drug Discov 2006 5 6 493 506 10.1038/nrd2060 16732220
4. Resveratrol, Sirtuins, and the Promise of a DR Mimetic. JA Baur, Mech Ageing Dev 2010 131 4 261 269 10.1016/j.mad.2010.02.007 20219519
5. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-[gamma]. F Picard M Kurtev N Chung A Topark-Ngarm T Senawong R Machado de Oliveira M Leid MW McBurney L Guarente, Nature 2004 429 6993 771 776 10.1038/nature02583 15175761
6. Resveratrol: biologic and therapeutic implications. S Sadruddin R Arora, J Cardiometab Synd 2009 4 2 102 6 10.1111/j.1559-4572.2008.00039.x
7. Central administration of resveratrol improves diet-induced diabetes. G Ramadori L Gautron T Fujikawa CR Vianna JK Elmquist R Coppari, Endocrinology 2009 150 12 5326 33 10.1210/en.2009-0528 19819963
8. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. L Rivera R Morán A Zarzuelo M Galisteo, Biochem Pharmacol 2009 77 6 1053 63 10.1016/j.bcp.2008.11.027 19100718
9. Resveratrol bioavailability and toxicity in humans. CH Cottart V Nivet-Antoine C Laguillier-Morizot JL Beaudeux, Mol Nutr Food Res 2010 54 1 10 10.1002/mnfr.200900437
10. Comparative analysis of microarray data identifies common responses to caloric restriction among mouse tissues. WR Swindell, Mech Ageing Dev 2008 129 3 138 53 10.1016/j.mad.2007.11.003 18155270
11. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. JN Feige M Lagouge C Canto A Strehle S Houten JC Milne PD Lambert C Mataki PJ Elliott J Auwerx, Cell Metab 2008 8 347 358 10.1016/j.cmet.2008.08.017 19046567
12. Resveratrol Improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1[alpha]. M Lagouge C Argmann Z Gerhart-Hines H Meziane C Lerin F Daussin N Messadeq J Milne P Lambert P Elliott B Geny M Laakso P Puigserver J Auwerx, Cell 2006 127 6 1109 1122 10.1016/j.cell.2006.11.013 17112576
13. Resveratrol treatment in mice does not elicit the bradycardia and hypothermia associated with calorie restriction. JR Mayers BW Iliff SJ Swoap, FASEB Journal 2009 23 1032 1040 10.1096/fj.08-115923 19056839
14. Resveratrol improves health and survival of mice on a high-calorie diet. JA Baur KJ Pearson NL Price HA Jamieson C Lerin A Kalra VV Prabhu JS Allard G Lopez-Lluch K Lewis PJ Pistell S Poosala KG Becker O Boss D Gwinn MY Wang S Ramaswamy KW Fishbein RG Spencer EG Lakatta D Le Couteur RJ Shaw P Navas P Puigserver DK Ingram R de Cabo DA Sinclair, Nature 2006 444 7117 337 342 10.1038/nature05354 17086191
15. Photoperiod-induced changes in energy balance in gray mouse lemurs. F Génin M Perret, Physiol Behav 2000 71 3-4 315 321 10.1016/S0031-9384(00) 00335-8 11150563
16. Daily rhythms of core temperature and locomotor activity indicate different adaptive strategies to cold exposure in adult and aged mouse lemurs acclimated to a summer-like photoperiod. J Terrien P Zizzari J Epelbaum M Perret F Aujard, Chronobiol Internat 2009 26 1 16 10.1080/07420520802694103
17. Gut hormones in relation to body mass and torpor pattern changes during food restriction and re-feeding in the gray mouse lemur. S Giroud M Perret Y Le Maho I Momken C Gilbert S Blanc, J Comp Physiol B 2008 179 1 99 111 10.1007/s00360-008-0294-4 18726602
18. Gut peptides in the regulation of food intake and energy homeostasis. KG Murphy WS Dhillo SR Bloom, Endocr Rev 2006 27 7 719 727 17077190
19. Effect of glucagon-like peptide-1 and -2 on regulation of food intake, body temperature and locomotor activity in the japanese quail. S Shousha K Nakahara T Nasu T Sakamoto N Murakami, Neurosci lett 2007 415 2 102 107 10.1016/j.neulet.2007.01.007 17267112
20. A role for pancreatic polypeptide in feeding and body weight regulation. S Kojima N Ueno A Asakawa K Sagiyama T Naruo S Mizuno A Inui, Peptides 2007 28 2 459 463 10.1016/j.peptides.2006.09.024 17207558
21. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. L Almeida M Vaz-da-Silva A Falco E Soares R Costa AI Loureiro C Fernandes-Lopes JF Rocha T Nunes L Wright P Soares-da-Silva, Mol Nutr Food Res 2009 53 7 S15 10.1002/mnfr.200890054 19194969
22. Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects. T Nunes L Almeida JF Rocha A Falco C Fernandes-Lopes AI Loureiro L Wright M Vaz-da-Silva P Soares-da-Silva, J Clin Pharmacol 2009 49 12 1477 1482 10.1177/0091270009339191 19797536
23. Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. ME Juan M Maijá JM Planas, J Pharmaceut Biomed 2010 51 2 391 398 10.1016/j.jpba.2009.03.026
24. Hibernation in the tropics: lessons from a primate. KH Dausmann J Glos JU Ganzhorn G Heldmaier, J Comp Physiol B 2005 175 3 147 155 10.1007/s00360-004- 0470-0 15682314
25. Energetics of tropical hibernation. K Dausmann J Glos G Heldmaier, J Comp Physiol B 2009 179 3 345 357 10.1007/s00360-008-0318-0 19048262
26. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. KJ Pearson JA Baur KN Lewis L Peshkin NL Price N Labinskyy WR Swindell D Kamara RK Minor E Perez HA Jamieson Y Zhang SR Dunn K Sharma N Pleshko LA Woollett A Csiszar Y Ikeno D Le Couteur PJ Elliott KG Becker P Navas DK Ingram NS Wolf Z Ungvari DA Sinclair R de Cabo, Cell Metab 2008 8 157 168 10.1016/j.cmet.2008.06.011 18599363
27. Small molecules activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo. JJ Smith RD Keeney D Gagne B Frushour W Ladd H Galonek K Israelian J Song G Razvadauskaite A Lynch D Carney R Johnson S Lavu A Iffland P Elliott P Lambert K Elliston M Jirousek J Milne O Boss, BMC Syst Biol 2009 3 31 10.1186/1752-0509-3-31 19284563
28. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. JC Milne PD Lambert S Schenk DP Carney JJ Smith DJ Gagne L Jin O Boss RB Perni CB Vu JE Bemis R Xie JS Disch PY Ng JJ Nunes AV Lynch H Yang H Galonek K Israelian W Choy A Iffland S Lavu O Medvedik DA Sinclair JM Olefsky MR Jirousek PJ Elliott CH Westphal, Nature 2007 450 712 716 10.1038/nature06261 18046409
29. Obesity treatment: novel peripheral targets. BC Field OB Chaudhri SR Bloom, Brit J Clin Pharmaco 2009 68 6 830 843 10.1111/j.1365-2125.2009.03522.x
30. Protein, amino acids, vagus nerve signaling, and the brain. D Tome J Schwarz N Darcel G Fromentin, Am J Clin Nutr 2009 90 3 838S 843S 10.3945/ajcn.2009.27462W 19640948
31. A role for glucagon-like peptide-1 in the central regulation of feeding. MD Turton D O'Shea I Gunn SA Beak CMB Edwards K Meeran SJ Choi GM Taylor MM Heath PD Lambert JPH Wilding DM Smith MA Ghatei J Herbert SR Bloom, Nature 1996 379 6560 69 72 10.1038/379069a0 8538742 (Pubitemid 26008136)
32. The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans. A Flint A Raben JF Rehfeld JJ Holst A Astrup, Int J obesity 2000 24 3 288 298 10.1038/sj.ijo.0801126
33. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. JJ Meier B Gallwitz WE Schmidt MA Nauck, Eur J Pharmacol 2002 440 2-3 269 279 10.1016/S0014-2999(02)01434-6 12007541
34. PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice. SH Adams C Lei CM Jodka SE Nikoulina JA Hoyt B Gedulin CM Mack ES Kendall, J Nutr 2006 136 1 195 201 16365082
35. Effects of glucose-dependent insulinotropic peptide on behavior. KH Ding Z Qing X Ding HX Chen MA Della-Fera RJ Bollag WB Bollag R Gujral K Baolin S Sridhar C Baile W Curl CM Isales, Peptides 2006 27 11 2750 2755 10.1016/j.peptides.2006.05.011 16822587
36. GIP biology and fat metabolism. RGC Yip MM Wolfe, Life Sci 1999 66 2 91 103 10.1016/S0024-3205(99)00314-8
37. Metabolic rate depression is induced by caloric restriction and correlates with rate of development and lifespan in a parthenogenetic insect. AM Roark KA Bjorndal, Exp Gerontol 2009 44 6-7 413 419 10.1016/j.exger.2009.03.004 19328225
38. Thermoregulatory responses to variations of photoperiod and ambient temperature in the lesser mouse lemur: a primitive or an advanced adaptive character? F Aujard M Perret G Vannier, J Comp Physiol B 1998 168 540 548 10.1007/s003600050175 9810718
39. Energy expenditure of rhesus monkeys subjected to 11 years of dietary restriction. S Blanc D Schoeller J Kemnitz R Weindruch R Colman W Newton K Wink S Baum J Ramsey, J Clin Endocr Metab 2003 88 1 16 23 10.1210/jc.2002-020405 12519821 (Pubitemid 36115135)
40. Influence of daylength on metabolic rate and daily water loss in the male prosimian primate Microcebus murinus. M Perret F Aujard G Vannier, Comp Biochem Phys A 1998 119 4 981 989 10.1016/S1095-6433(98)00015-4 (Pubitemid 28389210)